FDA rejection News
Most Popular FDA rejection Story
FDA rejects Discovery Labs' Surfaxin
Shares of Discovery Laboratories plunged today as the FDA announced that it wouldn't approve the company's drug Surfaxin for treatment of respiratory illness in infants. The agency's primary question Read more...
Latest Headlines
- June 24, 2011
- March 18, 2011
- July 22, 2010
- June 1, 2010
- March 19, 2010
- February 19, 2010
- December 3, 2009
- November 30, 2009
- October 21, 2009
- October 9, 2009
- August 18, 2009
- July 29, 2009
- July 1, 2009
- June 1, 2009
- May 20, 2009
- May 1, 2009
- April 20, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
